Stanley T. Crooke
E255305
Stanley T. Crooke is an American physician-scientist and biotechnology executive best known as the founder and longtime leader of Ionis Pharmaceuticals, a pioneer in antisense drug development.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Stanley T. Crooke canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T1169587 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Stanley T. Crooke Context triple: [Ionis Pharmaceuticals, foundedBy, Stanley T. Crooke]
-
A.
Frederick W. Lander
Frederick W. Lander was a 19th-century American civil engineer and explorer best known for surveying and constructing overland wagon routes to the western United States.
-
B.
James A. Allison
James A. Allison was an American entrepreneur and industrialist best known as one of the founders of the Indianapolis Motor Speedway and the Allison Engineering Company, a major aircraft engine manufacturer.
-
C.
Benjamin A. Vierling
Benjamin A. Vierling is an American artist known for his intricate, symbolically rich paintings that blend classical techniques with esoteric and mystical themes.
-
D.
Donald A. Henderson
Donald A. Henderson was an American epidemiologist who led the World Health Organization’s successful global campaign to eradicate smallpox.
-
E.
Donald F. Hornig
Donald F. Hornig was an American chemist and science advisor who served as a key presidential science counselor, notably to President Lyndon B. Johnson.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Stanley T. Crooke Target entity description: Stanley T. Crooke is an American physician-scientist and biotechnology executive best known as the founder and longtime leader of Ionis Pharmaceuticals, a pioneer in antisense drug development.
-
A.
Frederick W. Lander
Frederick W. Lander was a 19th-century American civil engineer and explorer best known for surveying and constructing overland wagon routes to the western United States.
-
B.
James A. Allison
James A. Allison was an American entrepreneur and industrialist best known as one of the founders of the Indianapolis Motor Speedway and the Allison Engineering Company, a major aircraft engine manufacturer.
-
C.
Benjamin A. Vierling
Benjamin A. Vierling is an American artist known for his intricate, symbolically rich paintings that blend classical techniques with esoteric and mystical themes.
-
D.
Donald A. Henderson
Donald A. Henderson was an American epidemiologist who led the World Health Organization’s successful global campaign to eradicate smallpox.
-
E.
Donald F. Hornig
Donald F. Hornig was an American chemist and science advisor who served as a key presidential science counselor, notably to President Lyndon B. Johnson.
- F. None of above. chosen
Statements (44)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology executive
ⓘ
company founder ⓘ human ⓘ physician-scientist ⓘ |
| citizenship | United States of America ⓘ |
| contributedTo |
clinical development of antisense drugs
ⓘ
establishing antisense as a drug discovery platform ⓘ |
| employer | Ionis Pharmaceuticals ⓘ |
| fieldOfWork |
RNA therapeutics
ⓘ
antisense technology ⓘ biotechnology ⓘ drug development ⓘ |
| founded | Ionis Pharmaceuticals ⓘ |
| givenName | Stanley ⓘ |
| hasAcademicBackgroundIn |
biochemistry
ⓘ
medicine ⓘ pharmacology ⓘ |
| hasFocus | genetic and rare diseases therapeutics ⓘ |
| hasGender | male ⓘ |
| hasLeadershipRoleIn | Ionis Pharmaceuticals ⓘ |
| hasRole |
RNA therapeutics pioneer
ⓘ
drug discovery leader ⓘ |
| industry |
biopharmaceutical industry
ⓘ
biotechnology industry ⓘ |
| knownFor |
founding Ionis Pharmaceuticals
ⓘ
leadership of Ionis Pharmaceuticals ⓘ pioneering antisense drug development ⓘ |
| name | Stanley T. Crooke ⓘ |
| nationality | United States of America ⓘ |
| notableAchievement | advancing antisense oligonucleotides into approved medicines ⓘ |
| notableFor | transforming antisense from concept to therapeutic platform ⓘ |
| notableWork | development of antisense oligonucleotide drugs at Ionis Pharmaceuticals ⓘ |
| occupation |
biotechnology executive
ⓘ
physician ⓘ scientist ⓘ |
| positionHeld |
chief executive officer of Ionis Pharmaceuticals
ⓘ
executive chairman of Ionis Pharmaceuticals ⓘ founder of Ionis Pharmaceuticals ⓘ |
| researchInterest |
RNA-targeted therapeutics
ⓘ
antisense oligonucleotides ⓘ drug safety and toxicology ⓘ |
| typeOfLeader | founder-CEO ⓘ |
| workLocation |
Carlsbad, California
ⓘ
linked to:
Carlsbad, California, United States
United States ⓘ
linked to:
United States of America
|
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Stanley T. Crooke Description of subject: Stanley T. Crooke is an American physician-scientist and biotechnology executive best known as the founder and longtime leader of Ionis Pharmaceuticals, a pioneer in antisense drug development.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.